Frontiers | CA19.9 Serum Level Predicts Lymph-Nodes Status in Resectable Pancreatic Ductal Adenocarcinoma: A Retrospective Single-Center Analysis
Identification and prognostic analysis of biomarkers to predict the progression of pancreatic cancer patients | Molecular Medicine | Full Text
Circulating stromal cells in resectable pancreatic cancer correlates to pathological stage and predicts for poor clinical outcomes | npj Precision Oncology
Circulating stromal cells in resectable pancreatic cancer correlates to pathological stage and predicts for poor clinical outcomes | npj Precision Oncology
Identification and prognostic analysis of biomarkers to predict the progression of pancreatic cancer patients | Molecular Medicine | Full Text
Consensus guidelines for diagnosis, treatment and follow-up of patients with pancreatic cancer in Spain | SpringerLink
Selective Labeling and Identification of the Tumor Cell Proteome of Pancreatic Cancer In Vivo | Journal of Proteome Research
Trends in Neoadjuvant Approaches in Pancreatic Cancer in: Journal of the National Comprehensive Cancer Network Volume 15 Issue 8 (2017)
Frontiers | CA19.9 Serum Level Predicts Lymph-Nodes Status in Resectable Pancreatic Ductal Adenocarcinoma: A Retrospective Single-Center Analysis
Treatment for potentially resectable exocrine pancreatic cancer - UpToDate
Frontiers | Predictive Biomarkers for a Personalized Approach in Resectable Pancreatic Cancer
Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up† - Annals of Oncology
Pancreatic Cancer CT: Prediction of Resectability according to NCCN Criteria | Radiology
Clinicodemographic aspect of resectable pancreatic cancer and prognostic factors for resectable cancer | World Journal of Surgical Oncology | Full Text
New Treatment Options and Management Considerations in Borderline Resectable Pancreatic Cancer
Frontiers | Predictive Biomarkers for a Personalized Approach in Resectable Pancreatic Cancer